Accessibility Menu
 
Evogene logo

Evogene

(NASDAQ) EVGN

Current Price$0.78
Market Cap$6.83M
Since IPO (2008)-94%
5 Year-98%
1 Year-38%
1 Month-8%

Evogene Financials at a Glance

Market Cap

$6.83M

Revenue (TTM)

$3.95M

Net Income (TTM)

$8.48M

EPS (TTM)

$-1.16

P/E Ratio

-0.67

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.78

Volume

44,617

Open

$0.78

Previous Close

$0.78

Daily Range

$0.77 - $0.81

52-Week Range

$0.72 - $2.42

EVGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evogene

Industry

Biotechnology

Employees

117

CEO

Ofer Haviv, CPA

Headquarters

Rehovot, 7414002, IL

EVGN Financials

Key Financial Metrics (TTM)

Gross Margin

35%

Operating Margin

-4%

Net Income Margin

-2%

Return on Equity

-655%

Return on Capital

-90%

Return on Assets

-42%

Earnings Yield

-1.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.83M

Shares Outstanding

8.72M

Volume

44.62K

Short Interest

0.00%

Avg. Volume

473.81K

Financials (TTM)

Gross Profit

$795.00K

Operating Income

$14.00M

EBITDA

$12.85M

Operating Cash Flow

$13.50M

Capital Expenditure

$135.00K

Free Cash Flow

$13.64M

Cash & ST Invst.

$12.99M

Total Debt

$2.20M

Evogene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$314.00K

-80.5%

Gross Profit

$53.00K

-120.2%

Gross Margin

-16.88%

N/A

Market Cap

$6.83M

N/A

Market Cap/Employee

$58.40K

N/A

Employees

117

N/A

Net Income

$5.31M

-1343.3%

EBITDA

$4.73M

-729.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.79M

+342.8%

Accounts Receivable

$1.88M

+26.6%

Inventory

$210.00K

-88.5%

Long Term Debt

$1.48M

-22.6%

Short Term Debt

$716.00K

-93.5%

Return on Assets

-42.32%

N/A

Return on Invested Capital

-89.78%

N/A

Free Cash Flow

$3.02M

+45.4%

Operating Cash Flow

$3.01M

+42.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMNNImunon, Inc.
$3.22+7.69%
CLRBCellectar Biosciences, Inc.
$2.55+2.00%
BOLTBolt Biotherapeutics, Inc.
$4.29-4.88%
DWTXDogwood Therapeutics, Inc.
$2.11-0.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About EVGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.